bioRxivMicrobiology
Taxonomic description and genome sequence of Christensenella intestinihominis sp. nov., a novel cholesterol-lowering bacterium isolated from human gut
Abstract
A Gram-staining-negative, non-spore-forming, short, straight rod, non-motile, obligate anaerobic bacterial strain, AF73-05CM02T, was isolated from faecal sample of thirty-years old healthy male. Colonies were approximately 0.2mm in diameter, beige and circular after 4 days of incubation on PYG agar under anaerobic conditions at 37{degrees}C. Strain AF73-05CM02T grew in a temperature range between 30-42{degrees}C and pH range from 6.0 to 8.5, with optimum growth at 37-42{degrees}C and pH 7.0. Base on the 16S rRNA gene sequence analysis, strain AF73-05CM02T belongs to the genus Christensenella and showed the highest level of sequence similarity with Christensenella minuta YIT 12065T. The predominant fatty acids of strain AF73-05CM02T were C10:0 (7.5%), iso-C11:0 (5.6%), C12:0 (7.2%), C14:0 (46.6%), iso-C15:0 (7.4%), C16:0 (9.7%) and C18:1 {omega} 9 c (6.9%). Acetic acid, formic acid, butyric acid and lactic acid were end products of glucose fermentation. The isolate was negative for catalase, indole production and hydrolysis of gelatin. Genomic relatedness analyses based on average nucleotide identity indicated strain AF73-05CM02T significantly differed from other species of the genus Christensenella, showing ANI values under 82.89% with the phylogenetically closest species. The G+C content of the genomic DNA was 52.07 mol% from genome sequence, which differs from that of Christensenella minuta. Several physiological biochemical and genotypic properties differentiated the novel bacterial strain from the related species, indicating that the isolate represent a new species of the genus Christensenella for which the name Christensenella intestinihominis sp. nov. is proposed, with strain AF73-05CM02T (=CGMCC 1.5207T =DSM 103477T) being the type strain. The follow study approached the function of cholesterol-lowering for strains AF73-05CM02T and DSM 22067T revealed the two strains exhibit capacity for removing cholesterol with efficiency of 36.6% and 54.3%. Exopolysaccharide production of two strains were 234 and 271 mg/L, respectively.
- organism: human
- assay: metagenomics
- research focus: ecology & biodiversity
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization and description of Faecalibacterium butyricigenerans sp. nov. and F. longum sp. nov., isolated from human faeces
- Description of a new member of the family Erysipelotrichaceae: Clostridium fusiformis sp. nov., isolated from healthy human feces
S. Ghimire, S. Wongkuna, J. Scaria·bioRxiv·Aug 13, 2019
- Butyribacter intestini gen. nov., sp. nov., a butyric acid-producing bacterium of the family Lachnospiraceae isolated from the human faeces, and reclassification of Acetivibrio ethanolgignens as Acetanaerobacter ethanolgignens gen. nov., comb. nov.
- Peptonella octanoica gen. nov., sp. nov., a new medium-chain carboxylate-producing bacterium, and the reclassification of Eubacterium pyruvativorans as Peptonella pyruvativorans comb. nov.
Dinesh Kumar Nallasamy, Blake G. Lindner, Christopher E. Lawson·bioRxiv·Aug 24, 2026
- Characterization and description of Clostridium filamentum ETTB, a novel gut bacterium with TLR5 modulating properties
Kassem Makki, Maria Elena Martino, … Fredrik Bäckhed·bioRxiv·Feb 28, 2025
- Expanding the cultivable human archaeome: Methanobrevibacter intestini sp. nov. and strain Methanobrevibacter smithii GRAZ-2 from human feces
Viktoria Weinberger, Rokhsareh Mohammadzadeh, … Christine Moissl‐Eichinger·INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGYPeer-reviewed·Apr 16, 2025